IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The compan...
FY 2026
May 15, 2026
Q4 2026
Q3 2026
Feb 18, 2026
Q2 2026
Nov 14, 2025
Q1 2026
Aug 14, 2025